NCT00611351 2023-10-23Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic CancerUniversity of NebraskaPhase 2 Completed5 enrolled 10 charts
NCT00567229 2015-11-20Lenalidomide and Rituximab in Treating Patients With Recurrent and/or Refractory Multiple MyelomaMemorial Sloan Kettering Cancer CenterPhase 2 Terminated3 enrolled 6 charts
NCT00616720 2011-05-16Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple MyelomaMayo ClinicPhase 2 Completed15 enrolled
NCT00410657 2010-05-14Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell TransplantFred Hutchinson Cancer CenterPhase 2 Completed53 enrolled